Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Petrol Diesel Prices
Char Dham Yatra
Gyanvapi Mosque
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Centre issues a new Letter of Comfort to Bharat Biotech
India

Centre issues a new Letter of Comfort to Bharat Biotech

Centre issues a new Letter of Comfort to Bharat Biotech
Written by Nikita Gupta
(Sourced from PTI)
Edited by Anamica Singh
Jan 19, 2021, 06:39 pm 2 min read
Centre issues a new Letter of Comfort to Bharat Biotech

Bharat Biotech secured a fresh Letter of Comfort from the Centre for 45 lakh doses of its COVID-19 vaccine, COVAXIN. Out of those 45 lakh doses, over eight lakh doses will be supplied to friendly countries like Mauritius, the Philippines, and Myanmar free of cost, as a goodwill gesture. The company will dispatch 20 lakh doses of the earlier order in a couple of days.

Order
First batch of COVAXIN was shipped to eleven cities

The 45 lakh doses will be dispatched when the Ministry places orders with the company. Previously, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Vijayawada, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru, Pune, Bhubaneswar, Jaipur, Chennai, and Lucknow, after having received the government purchase order for 55 lakh doses. Bharat Biotech also donated 16.5 lakh doses to the Union Government.

Order and supply
MEA to look over the dispatch to various nations

Unlike regular tenders, the COVAXIN order doesn't fall into orders with timelines. It is dispatched in bits and pieces on the Ministry's call. Every fortnight, the Centre convenes a meeting through video conferencing with vaccine manufacturers and other stakeholders to ensure the proper supply-chain management is in place. The Ministry of External Affairs will monitor the supply of eight lakh doses to various countries.

Approval
COVAXIN was granted authorization for restricted use in emergency situations

COVAXIN was granted approval for restricted use in emergency situations in public interest as an abundant precaution, in clinical trial mode. It is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and the National Institute of Virology. The vaccine is developed and manufactured at Bharat Biotech's BSL-3 biocontainment facility, one of its kind in the world.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Nikita Gupta <br/><i>(Sourced from PTI)</i>
Nikita Gupta
(Sourced from PTI)
Mail
An Indian Institute of Journalism and New Media (IIJNM) graduate, Nikita holds a keen interest in traveland lifestyle writing. A wallflower by nature, she consumes books like food. Mythology lover, feministand tries to run a blog when she is not binge-watching, art-journaling or scrolling through Instagram.
Anamica Singh
Anamica Singh
Twitter
Anamica Singh is a lifestyle editor at NewsBytes. Having started as a sports journalist, she has covered entertainment, national and international news over her 14-year-long career. She is experienced in news writing, video production, anchoring, and voiceovers. Her past stints include her time at Mobile ESPN, IANS, and MSN. She holds a Bachelor’s degree in Political Science from the University of Delhi and a postgraduate diploma in journalism from YMCA, Delhi.
Latest
Coronavirus
Bharat Biotech
COVAXIN
Related
Latest
As Modi visits Hyderabad today, KCR takes detour to Bengaluru
As Modi visits Hyderabad today, KCR takes detour to Bengaluru Politics
5 effective tips to say no politely and guilt-free
5 effective tips to say no politely and guilt-free Lifestyle
5 most scenic rail routes in India
5 most scenic rail routes in India Lifestyle
Redmi Note 11SE debuts with MediaTek Dimensity 700 SoC
Redmi Note 11SE debuts with MediaTek Dimensity 700 SoC Technology
Top 5 biographical movies that Hollywood has churned out
Top 5 biographical movies that Hollywood has churned out Entertainment
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Bharat Biotech
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
Are Indian vaccines effective against Omicron? Here's what manufacturers say
Are Indian vaccines effective against Omicron? Here's what manufacturers say India
COVAXIN gets WHO approval for emergency use listing
COVAXIN gets WHO approval for emergency use listing India
More News
COVAXIN
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
More News
Related
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN India
COVAXIN 77.8% effective; government panel reviews Phase III trial data
COVAXIN 77.8% effective; government panel reviews Phase III trial data India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022